Open AccessClinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred’s experience
Author(s) -
Wirawan Jeong,
Greg Snell,
Bronwyn Levvey,
Glen P. Westall,
C. Orla Morrissey,
S. Ivulich,
Chin Fen Neoh,
Monica A. Slavin,
David C. M. Kong
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx085
Subject(s) - posaconazole , medicine , voriconazole , aspergillus fumigatus , therapeutic drug monitoring , aspergillosis , cmin , surgery , antifungal , immunology , pharmacokinetics , dermatology , cmax
This study describes the clinical outcomes and therapeutic drug monitoring (TDM) following posaconazole suspension pre-emptive therapy in lung transplant (LTx) recipients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom